Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinoma

Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinoma

Background/Purpose: Gadoxetate disodium-enhanced magnetic resonance imaging (EOB-MRI) has a higher diagnostic accuracy for hepatocellular carcinoma (HCC) than computed tomography (CT). However, indications for performing EOB-MRI after dynamic CT are not well defined. Therefore, we investigated the c...

Full description

Bibliographic Details
Main Authors:	Chih-Horng Wu, Yu-Hsin Lee, Po-Chin Liang, Rey-Heng Hu, Tiffany Ting-Fang Shih, Ming-Chih Ho
Format:	Article
Language:	English
Published:	Elsevier 2022-08-01
Series:	Journal of the Formosan Medical Association
Subjects:	Neoplasm staging Hepatocellular carcinoma Computed tomography Gadoxetic acid Magnetic resonance imaging
Online Access:	http://www.sciencedirect.com/science/article/pii/S0929664621005933

Similar Items

Development and External Validation of a Radiomics Model Derived from Preoperative Gadoxetic Acid-Enhanced MRI for Predicting Histopathologic Grade of Hepatocellular Carcinoma
by: Xiaojun Hu, et al.
Published: (2023-01-01)

Liver-specific gadoxetic acid-enhanced magnetic resonance for focal lesion evaluation
by: P.E. Cossio-Torrico, et al.
Published: (2015-10-01)

Predictive models and early postoperative recurrence evaluation for hepatocellular carcinoma based on gadoxetic acid-enhanced MR imaging
by: Qian Li, et al.
Published: (2023-01-01)

Gadolinium deposition in the liver and brain in a rat model with liver fibrosis after intravenous administration of gadoxetate disodium
by: Peiying Wei, et al.
Published: (2024-03-01)

Gadoxetic acid–enhanced MRI with a focus on LI-RADS v2018 imaging features predicts the prognosis after radiofrequency ablation in small hepatocellular carcinoma
by: Ruizhi Wang, et al.
Published: (2023-02-01)

Gadoxetic Acid-Based MRI for Decision-Making in Hepatocellular Carcinoma Employing Perfusion Criteria Only—A Post Hoc Analysis from the SORAMIC Trial Diagnostic Cohort
by: Max Seidensticker, et al.
Published: (2022-01-01)

Evaluation of high temporal resolution magnetic resonance imaging of the liver with gadoxetate disodium in combination with compressed sensing and parallel imaging under single breath-holding using a 1.5-T magnetic resonance system
by: Fumiaki Fukamatsu, et al.
Published: (2024-03-01)

The MR imaging diagnosis of liver diseases using gadoxetic acid: Emphasis on hepatobiliary phase
by: Woo Kyoung Jeong, et al.
Published: (2013-12-01)

Predicting histologic differentiation of solitary hepatocellular carcinoma up to 5 cm on gadoxetate disodium-enhanced MRI
by: Ting Yang, et al.
Published: (2023-01-01)

Comment on “Predictors of changes in preoperative tumor stage between dynamic computed tomography and gadoxetate disodium-enhanced magnetic resonance imaging for hepatocellular carcinoma”
by: Linyan Gong, et al.
Published: (2022-12-01)

Correction of Arterial-Phase Motion Artifacts in Gadoxetic Acid-Enhanced Liver MRI Using an Innovative Unsupervised Network
by: Feng Pan, et al.
Published: (2023-10-01)

Determination of hepatic extraction fraction with gadoxetate low‐temporal resolution DCE‐MRI‐based deconvolution analysis: validation with ALBI score and Child‐Pugh class
by: Monchai Phonlakrai, et al.
Published: (2023-04-01)

Comparison of <sup>68</sup>Ga-DOTATATE Positron Emmited Tomography/Computed Tomography and Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for the Detection of Liver Metastases from Well-Differentiated Neuroendocrine Tumors
by: Moran Drucker Iarovich, et al.
Published: (2024-01-01)

Radiomics nomogram for prediction of microvascular invasion in hepatocellular carcinoma based on MR imaging with Gd-EOB-DTPA
by: Shuai Zhang, et al.
Published: (2022-11-01)

Prediction of microvascular invasion in hepatocellular carcinoma based on preoperative Gd-EOB-DTPA-enhanced MRI: Comparison of predictive performance among 2D, 2D-expansion and 3D deep learning models
by: Tao Wang, et al.
Published: (2023-02-01)

Comparison of international guidelines for diagnosis of hepatocellular carcinoma and implications for transplant allocation in liver transplantation candidates with gadoxetic acid enhanced liver MRI versus contrast enhanced CT: a prospective study with liver explant histopathological correlation
by: Devang Odedra, et al.
Published: (2022-10-01)

Comparison of gadoxetic acid and gadobenate dimeglumine, liver-specific contrast agents used in magnetic resonance imaging in differential diagnosis of liver masses
by: Mehmet Akcicek, et al.
Published: (2020-03-01)

A case of focal nodular hyperplasia-like lesion presenting unusual signal intensity on the hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance image
by: Kumi Ozaki, MD, PhD, et al.
Published: (2023-09-01)

Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC
by: Roberto Cannella, et al.
Published: (2022-05-01)

Pharmacoeconomic Study on the Application of Magnetic Resonance Imaging with Gadoxetic Acid in Addition to Contrast-Enhanced Computed Tomography in Diagnosis of Hepatocellular Carcinoma
by: G. G. Kаrmаzаnovsky, et al.
Published: (2021-11-01)

Does Hepatic Steatosis Influence the Detection Rate of Metastases in the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI?
by: Ingo G. Steffen, et al.
Published: (2020-12-01)

Liver Functional Evaluation Using Gadoxetic Acid Versus the Gold Standard Hepatobiliary Scintigraphy in Patients with Bile Duct Diseases
by: M. A. Shorikov, et al.
Published: (2019-09-01)

Screening and Early Diagnosis of Hepatocellular Cancer and Optimization of Diagnostic Imaging Techniques: A Review and Conclusion of the Expert Panel
by: V. V. Breder, et al.
Published: (2023-02-01)

Assessment of Liver Metastases Using CT and MRI Scans in Patients with Pancreatic Ductal Adenocarcinoma: Effects of Observer Experience on Diagnostic Accuracy
by: Masakatsu Tsurusaki, et al.
Published: (2020-06-01)

Advancing Korean nationwide registry for hepatocellular carcinoma: a systematic sampling approach utilizing the Korea Central Cancer Registry database
by: Bo Hyun Kim, et al.
Published: (2024-03-01)

Preoperative predictors for non-resectability in perihilar cholangiocarcinoma
by: Carlos Constantin Otto, et al.
Published: (2024-02-01)

Focal Liver Lesion MRI Feature Identification Using Efficientnet and MONAI: A Feasibility Study
by: Róbert Stollmayer, et al.
Published: (2022-05-01)

A radiomics model based on preoperative gadoxetic acid–enhanced magnetic resonance imaging for predicting post-hepatectomy liver failure in patients with hepatocellular carcinoma
by: Changfeng Li, et al.
Published: (2023-07-01)

Trends in hepatocellular carcinoma stage by racial/ethnic group in the United States, 1992–2019
by: Christian S. Alvarez, et al.
Published: (2023-11-01)

A gadoxetic acid-enhanced MRI-based model using LI-RADS v2018 features for preoperatively predicting Ki-67 expression in hepatocellular carcinoma
by: Yingying Liang, et al.
Published: (2024-01-01)

Preoperative Prediction of Microvascular Invasion with Gadoxetic Acid-Enhanced Magnetic Resonance Imaging in Patients with Single Hepatocellular Carcinoma: The Implication of Surgical Decision on the Extent of Liver Resection
by: Na Reum Kim, et al.
Published: (2023-07-01)

Preoperative prediction of cytokeratin-19 expression for hepatocellular carcinoma using T1 mapping on gadoxetic acid-enhanced MRI combined with diffusion-weighted imaging and clinical indicators
by: Yue Zhao, et al.
Published: (2023-01-01)

Prospective evaluation of Gadoxetate-enhanced magnetic resonance imaging and computed tomography for hepatocellular carcinoma detection and transplant eligibility assessment with explant histopathology correlation
by: Kartik S. Jhaveri, et al.
Published: (2023-02-01)

Portal hypertension may influence the registration of hypointensity of small hepatocellular carcinoma in the hepatobiliary phase in gadoxetic acid MR
by: Caparroz Carla, et al.
Published: (2022-08-01)

Computed Tomography-Defined Sarcopenia in Outcomes of Patients with Unresectable Hepatocellular Carcinoma Undergoing Radioembolization: Assessment with Total Abdominal, Psoas, and Paraspinal Muscles
by: Chih-Horng Wu, et al.
Published: (2023-02-01)

Intermediate-stage hepatocellular carcinoma: refining substaging or shifting paradigm?
by: Bernardo Stefanini, et al.
Published: (2024-03-01)

Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI
by: Adele Taibbi, et al.
Published: (2019-03-01)

Evaluation of late arterial acquisition and image quality after gadoxetate disodium injection using the CDT-VIBE sequence
by: Fen Liu, et al.
Published: (2022-07-01)

Primary hepatocellular carcinoma in ectopic liver masquerading as left adrenal carcinoma: a rare occurrence
by: Shailendra Kumar, et al.
Published: (2010-06-01)

Dynamic PET/CT with the Hepatobiliary Tracer [68Ga]Ga-Tmos-DAZA for Characterization of a Hepatic Tumor
by: Martin Freesmeyer, et al.
Published: (2021-04-01)